Pure Global
NCT01828775

Palliative Care Intervention in Improving Quality of Life, Psychological Distress, and Communication in Patients With Solid Tumors Receiving Treatment

Integration of Palliative Care for Cancer Patients on Phase I Trials
City of Hope Medical Center·ClinicalTrials.gov·otherCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Unspecified Adult Solid Tumor, Protocol Specific
Drug/Device/Intervention
palliative care
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
City of Hope Medical Center
Location
Duarte,Baltimore, United States of America
Timeline & enrollment
Phase
N/A
Start date
Sep 08, 2014
End date
May 18, 2020
Enrollment
480 participants
Primary outcome

Change in overall QOL scores, assessed by the Functional Assessment of Cancer Therapy-General (FACT-G) and Functional Assessment of Chronic Illness Therapy-Spirituality (FACIT-Sp),Change in psychological distress, assessed using the Psychological Distress Thermometer,Satisfaction with communication, measured by the Family Satisfaction with Advanced Cancer Care (FAMCARE),Patients' symptom intensity and symptom interference with daily activities,Total numbers of supportive care referrals (social work, dietitian, chaplaincy, psychologist/psychiatrist),Total number of unscheduled outpatient encounters and inpatient admissions,Total number of hospice referrals,Retention on the Phase I trial,Patient satisfaction with the PCI

Summary

This pilot randomized clinical trial studies palliative care intervention in improving
 quality of life, psychological distress, and communication in patients with solid tumors
 receiving treatment on phase I trials. Cancer patients experience many symptoms related to
 treatment and the cancer itself that can be distressing and impact quality of life.
 Palliative care focuses on managing these symptoms and may help patients with solid tumors
 live more comfortably.

ICD-10 classifications
Carcinoma in situ, unspecifiedMalignant neoplasm, without specification of siteMalignant neoplasm, primary site unspecifiedCarcinoma in situ of other and unspecified genital organsMalignant neoplasm: Connective and soft tissue, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT01828775
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT01828775 through Pure Global AI's free database. This phase not specified trial is sponsored by City of Hope Medical Center and is currently Completed. The study focuses on Unspecified Adult Solid Tumor, Protocol Specific. Target enrollment is 480 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.